31. A Bayesian Sequential Design for Clinical Trials With Time-to-Event Outcomes. (2nd October 2019) Authors: Zhu, Lin; Yu, Qingzhao; Mercante, Donald E. Journal: Statistics in biopharmaceutical research Issue: Volume 11:Number 4(2019) Page Start: 387 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
32. A Bayesian sequential design with adaptive randomization for 2‐sided hypothesis test. (4th October 2017) Authors: Yu, Qingzhao; Zhu, Lin; Zhu, Han Journal: Pharmaceutical statistics Issue: Volume 16:Number 6(2017) Page Start: 451 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
33. A Bayesian sequential design with binary outcome. (2nd March 2017) Authors: Zhu, Han; Yu, Qingzhao; Mercante, Donald E. Journal: Pharmaceutical statistics Issue: Volume 16:Number 3(2017) Page Start: 192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
34. A Bayesian three-parameter logistic model for early- and late-onset DLTs in oncology Phase I studies. Issue 2 (3rd March 2016) Authors: Zheng, Wei; Zhao, Yang; Lu, Yuefeng; Miao, Harry; Liu, Hengchang Journal: Journal of biopharmaceutical statistics Issue: Volume 26:Issue 2(2016) Page Start: 339 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
35. A Bayesian three-tier quantitative decision-making framework for single arm studies in early phase oncology. Issue 1 (2nd January 2023) Authors: Liu, Zhuqing; Liu, Jingyi; Xia, Meng Journal: Journal of biopharmaceutical statistics Issue: Volume 33:Issue 1(2023) Page Start: 60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
36. A Bayesian zero-inflated binomial regression and its application in dose-finding study. Issue 2 (3rd March 2020) Authors: Wanitjirattikal, Puntipa; Shi, Chenyang Journal: Journal of biopharmaceutical statistics Issue: Volume 30:Issue 2(2020) Page Start: 322 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
37. A case study in identifying targeted patients population in major depressive disorder by enhanced enrichment design. (19th November 2017) Authors: Zhang, Peter; Carroll, Kevin; Hobart, Mary; Augustine, Carole; Koch, Gary Journal: Pharmaceutical statistics Issue: Volume 17:Number 2(2018) Page Start: 144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
38. A case study of an adaptive design for a clinical trial with 2 doses and 2 endpoints in a rare disease area. (16th September 2018) Authors: Quan, Hui; Xu, Yi; Chen, Yixin; Gao, Lei; Chen, Xun Journal: Pharmaceutical statistics Issue: Volume 17:Number 6(2018) Page Start: 797 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
39. A causal modelling framework for reference-based imputation and tipping point analysis in clinical trials with quantitative outcome. Issue 2 (3rd March 2020) Authors: White, Ian R.; Joseph, Royes; Best, Nicky Journal: Journal of biopharmaceutical statistics Issue: Volume 30:Issue 2(2020) Page Start: 334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
40. A causal modelling framework for reference-based imputation and tipping point analysis in clinical trials with quantitative outcome. Issue 2 (3rd March 2020) Authors: White, Ian; Joseph, Royes; Best, Nicky Journal: Journal of biopharmaceutical statistics Issue: Volume 30:Issue 2(2020) Page Start: 334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗